Monthly luncheon program for entrepreneurial faculty, bioscience company leaders, investors, technology transfer professionals, corporate development executives and professional service firms.
11:30 am - 1:30 pm, networking begins at 11:30, program begins at 12:00
Virginia Biotechnology Research Park
800 E. Leigh St.
Robert Ball Conference Center
Richmond, VA 23219
Online registration is closed.
Title: New directions in science and business at Health Diagnostic Laboratory, Inc. (HDL, Inc.), and opportunities for collaboration
Details: Health Diagnostic Laboratory, Inc. ("HDL, Inc.”) in under
five years has grown from a few founders to more than 700 employees and
two six-story laboratory facilities in the Virginia BioTechnology
Research Park in Richmond.
HDL, Inc. provides the most comprehensive
laboratory test menu of biomarkers and risk factors available, enabling
patients and their doctors to practice proactive health and medicine.
HDL, Inc. is reinventing the blood lab industry, and making major
contributions to patient outcomes across the country and world,
particularly in cardiovascular and related disease and diabetes.
HDL’s experience, capabilities and resources have grown, its passion for
innovation and for making a difference in personal health management
around the world is leading it to explore new and additional
technologies and unmet needs, through in licensing, joint ventures and
other collaborative models. In this panel, business and science leaders
from HDL will describe recent collaborations, and identify directions,
goals and needs of the company going forward with an emphasis on areas
of potential collaboration.
Speakers: Dr. Szilard Voros, Chief
Clinical Strategy Officer- HDL, Inc.; Mark Herzog, SVP, Corporate and
Governmental Affairs- HDL, Inc.; Brad Brown, VP, Clinical Affairs-
Global Genomics Group; and Idean Marvasty, VP Finance & Operations-
Global Genomics Group